Navigation Links
New Mask Study Supports CDC's Updated Guidance for Seasonal Flu Prevention Strategies
Date:9/29/2010

devices," said Gary Steinberg, CEO of Crosstex International.  "It was clear that medical face masks were being narrowly compared to N95 respirators for their ability to protect the wearer from the outside-in.  We wanted to better understand the value of medical face masks for source control, that is, protecting others from the inside-out," said Matt Conlon, Vice President at Cantel Medical.  While medical face masks are commonly referred to as "PPE" (Personal Protection Equipment), their original purpose was to protect the patient from acquiring an infection from the physician.  This new research is the first to quantify their important role in controlling the infection at the source and further demonstrated that a tighter fitting medical mask performs best in source control.  

The findings come in the wake of the 2009 H1N1 pandemic when there were significant complications, shortages, and debate surrounding the CDC's formal recommendation for the use of N95's by healthcare workers for protection against the H1N1 virus. Steinberg said, "This shows an exponential infection control benefit at a fraction of the cost and complexity of using N95 respirators.  As one of the few remaining U.S. manufacturers of medical masks, it is important for Crosstex to continue funding this type of independent research to address infectious disease threats through continued mask innovation. We don't overlook the fact that masks are medical devices.  We understand they can save lives and dramatically reduce costs associated with respiratory-borne infections."

About Crosstex International, Inc.

A division of Cantel Medical Corp., Crosstex manufactures a wide array of infection prevention and control products for the healthcare industry.  Founded in 1953 and headquartered in Hauppauge, New York, Crosstex sells branded and private label products including face masks, which are 100% manufactured in its FDA-registered
'/>"/>

SOURCE Crosstex International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
2. Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeichs Combo™ Bio-engineered Sirolimus Eluting Stent
3. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
4. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
5. Independent Community Pharmacies Earn High Customer Satisfaction Scores in Latest J.D. Power and Associates National Pharmacy Study
6. 12-Month Study Reports Efficacy Rates for AMS Elevate Apical and Posterior Prolapse Repair System
7. Facelift Healing Innovation: New Study Shows Hyperbaric Oxygen Therapy Decreases Bruising in Facelifts Patients by 35%
8. Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
9. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
10. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
11. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. ... Company will host a webcast conference call to report ... update on the company,s business and outlook on Thursday, ... opening of the market. The call ... (973) 935-8152 (international) five minutes prior to the start ...
(Date:7/24/2014)... Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... First quarter overview: , Revenues of $47.5 million, ... Diluted EPS of $0.21, up 50% over last year,s ... market revenues of $7.2 million, up 20% over last ...
(Date:7/24/2014)... July 24, 2014 IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, today announced it has ... of Directors.  Mr. Finio has accepted a senior level ... terms of his acceptance of his new position, Mr. ... as Director for IGI Laboratories, Inc.  The effective date ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... , , , , ... Inc. (Nasdaq: RIGL ) today announced that in the ... had failed to respond to at least one biologic treatment, the ... ACR 20, ACR 50, ACR 70 and DAS28 response rates than ...
... , G rowth ... for cardiac stem cells , ... regrow, but researchers at Children,s Hospital Boston have now laid the groundwork for ... in children with congenital heart defects. In the July 24 issue of ...
Cached Medicine Technology:R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent 8Injection Reverses Heart-Attack Damage 2Injection Reverses Heart-Attack Damage 3
(Date:7/25/2014)... 2014 As reported by the Statesman Journal ... Heroin (7/20), police in Salem, MA as well as ... the recent heroin epidemic that has taken many lives during ... heroin-related overdose case in which police were able to make ... phone. By pretending to be the victim and claiming to ...
(Date:7/25/2014)... of America (GSA) the nation,s largest ... has chosen Heather M. Young, PhD, RN, ... the 2014 recipient of the Doris Schwartz Gerontological ... by GSA,s Health Sciences Section, is given to ... outstanding and sustained contribution to gerontological nursing research. ...
(Date:7/25/2014)... Hospital and MOSI officially announced a transformational partnership that will ... make a difference in the Tampa Bay community. Florida Hospital ... the support needed to keep the science center moving forward. ... Dome Theatre from film to a state-of-the-art digital 3D projection ... the state of Florida, and it is one of the ...
(Date:7/25/2014)... 25, 2014 Art of Facial Surgery has ... those in Toronto who are looking for minor touch-ups to ... done by the American Academy of Facial Plastic and Reconstructive ... in facial plastic surgery showed a surprising increase between 2012 ... percent, while hair transplants increased by 7 percent and eyelid ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 ... , a Nuanced Media client and the nation’s ... and dental employee handbooks, announced their partnership with ... TransAct is a registered ISO/MSP of Chase Paymentech ... the transaction processing industry. Companies that are members ...
Breaking Medicine News(10 mins):Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2
... The following is a,statement of Matthew L. Myers President, ... Two new reports released today by the U.S. ... adult smoking rate in the United States,has declined to ... rates are,not declining fast enough to reduce tobacco,s growing ...
... presidential candidate John Edwards and breast cancer ... of preserving in tough times, FERNDALE, Mich., Nov. 13 ... finding hope and inspiration in,life,s challenges to the Troy Hilton, ... Company and Metro Parent Magazine are proud to,present this unique ...
... one day lead to vaccine that works , , THURSDAY, Nov. ... AIDS vaccine has failed, but researchers report that they,ve still ... effective. , "It,s raised a whole new set of questions ... get us to a successful vaccine," said Dr. Susan P. ...
... Diluted Share, FARMINGDALE, N.Y., Nov. 13 Misonix, ... ultrasonic medical device,technology, which in Europe is used for ... conditions, today reported financial,results for its fiscal year 2009 ... President and Chief Executive Officer, and Richard,Zaremba, Senior VP ...
... In the December issue of European Urology ... associates report on the evidence of a relationship ... (LUTS) in men enrolled in the REDUCE trial. ... Cancer Events) trial is a 4-year, phase-III placebo-controlled ...
... Northridge Hospital Medical,Center (Northridge) credits TeleHealth Services, ... the organization,s recent awards and top,accreditation, all ... comfort as its medical experts provide superior ... acute care facility located in Northridge, CA,Northridge ...
Cached Medicine News:Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 2Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 3Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 4Health News:Elizabeth Edwards Reschedules Metro Detroit Appearance 2Health News:HIV Vaccine Failure Still Brings Insights 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 3Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 4Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 5Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 6Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 7Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 8Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 9Health News:Relationship between prostate information and lower urinary-tract symptoms evident 2Health News:TeleHealth Services' TIGR(R) Interactive Patient Education System Facilitates Award-Winning Results at Northridge Hospital Medical Center 2Health News:TeleHealth Services' TIGR(R) Interactive Patient Education System Facilitates Award-Winning Results at Northridge Hospital Medical Center 3